Inflammation in a Translational Perspective

Healthcare11/15/2023 3:30 PM

Go to Registration Page


Experimental and clinical evidence have established the pathophysiological importance of pro-inflammatory pathways in coronary artery disease. Recent data from the PROMINENT, REDUCE-IT, and STRENGTH studies have shown that residual inflammatory risk is strongly associated with recurrent cardiovascular events, cardiovascular death, and all-cause mortality; and clinical trials of anti-inflammatory drugs, the LoDoCo2 and COLCOT studies, have shown reductions in risk of major adverse cardiovascular events in patients with stable atherosclerosis and after recent myocardial infarction. In this basic science webinar, we investigate the role of humoral immunity and IgM antibodies specifically in the progression of atherosclerosis, and inflammation in atherosclerotic events.


Rate This Webinar

community rating (0 votes): 
Rate or Review This Webinar


European Atherosclerosis Society

European Atherosclerosis Society

The European Atherosclerosis Society (EAS) is a society dedicated to the research, prevention, and treatment of atherosclerosis and related diseases. EAS brings together researchers, healthcare professionals, and scientists from around the world to advance knowledge and improve patient care in the field. Through educational programs, publications, grants, and collaborative efforts, EAS strives to combat atherosclerosis and promote cardiovascular health.